Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thi Ha Chau TRAN, PhD
Groupement des Hôpitaux de l'Institut Catholique de Lille
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pr Milazzo Solange
Amiens, Hauts-de-France, France
- Tran Thi Ha Chau
Lomme, Hauts-de-France, France
- Stéphanie Baillif
Nice, PACA, France
- Bénédicte Dupas
Paris, Île-de-France Region, France
- Dr Dominguez
Bordeaux, France
- Pr Kodjikian
Lyon, France
- Dr Franck Becquet
Nantes, France
- Dr Uzzan
Rouen, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Nov 2016
- Primary completion
- 19 Aug 2020
- Completion
- 19 Aug 2020
- Last update posted
- 5 Feb 2021
- Registered enrollment
- 49
- Registry id
- NCT02874859
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.